Literature DB >> 1717127

Endometrial carcinoma with trophoblastic differentiation. An aggressive form of uterine cancer.

C Pesce1, M J Merino, J T Chambers, F Nogales.   

Abstract

Three cases of poorly differentiated endometrial adenocarcinoma showing trophoblast-like differentiation are reported. The multinucleated, syncytiotrophoblast-like cells were strongly positive for beta-human chorionic gonadotropin (beta-HCG) by immunohistochemical study. High levels of beta-HCG were also present in the patients' serum, but dropped significantly after treatment. The patients had an unusually rapid and progressive clinical course with widespread dissemination and death by tumor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717127     DOI: 10.1002/1097-0142(19911015)68:8<1799::aid-cncr2820680825>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta.

Authors:  Reiner Strick; Sven Ackermann; Manuela Langbein; Justine Swiatek; Steffen W Schubert; Said Hashemolhosseini; Thomas Koscheck; Peter A Fasching; Ralf L Schild; Matthias W Beckmann; Pamela L Strissel
Journal:  J Mol Med (Berl)       Date:  2006-10-26       Impact factor: 4.599

Review 2.  Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein: A case report and literature review.

Authors:  He Cai; Rong Zhou; Wanying Liang; Jianliu Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

3.  Endometrioid adenocarcinoma with choriocarcinomatous differentiation: A case report and review of the literature.

Authors:  Mitsuaki Ishida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2013-06-28       Impact factor: 2.967

4.  Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum β-hCG: a case report and literature review.

Authors:  Mingliang Ji; Yan Lu; Lina Guo; Fengzhi Feng; Xirun Wan; Yang Xiang
Journal:  Onco Targets Ther       Date:  2013-10-24       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.